These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 26028398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complementing insulin therapy to achieve glycemic control.
    Barnett AH.
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [Abstract] [Full Text] [Related]

  • 6. Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
    DeGeeter M, Williamson B.
    J Pharm Pract; 2016 Apr; 29(2):144-59. PubMed ID: 25312263
    [Abstract] [Full Text] [Related]

  • 7. Clinical decisions. Glycemic management in a patient with type 2 diabetes.
    Hirsch IB, Molitch ME.
    N Engl J Med; 2013 Oct 03; 369(14):1370-2. PubMed ID: 24088099
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes.
    Home P.
    Diabetes Technol Ther; 2012 Jun 03; 14 Suppl 1():S33-42. PubMed ID: 22650223
    [Abstract] [Full Text] [Related]

  • 9. Which oral agent to use when metformin is no longer effective?
    Bannon M.
    QJM; 2011 Mar 03; 104(3):183-4. PubMed ID: 21330402
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.
    Scheen AJ.
    Expert Opin Drug Metab Toxicol; 2014 Jun 03; 10(6):839-57. PubMed ID: 24669954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis.
    Zhang X, Zhao Q.
    J Hypertens; 2016 Feb 03; 34(2):167-75. PubMed ID: 26682782
    [Abstract] [Full Text] [Related]

  • 13. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE.
    Endocrinol Metab Clin North Am; 2007 Dec 03; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract] [Full Text] [Related]

  • 14. PURLs: Need an add-on to metformin? Consider this.
    Wyncott D, Lyon C, Mounsey A.
    J Fam Pract; 2017 Jan 03; 66(1):42-44. PubMed ID: 28188318
    [Abstract] [Full Text] [Related]

  • 15. Initiating oral anti diabetic drug: alternatives to metformin.
    Kalra S, Gupta Y.
    J Pak Med Assoc; 2015 Apr 03; 65(4):440-1. PubMed ID: 25976586
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.